Why the study?
Does a reversible abnormal TAPSE (right ventricular recovery) improve survival in patients with chronic HFrEF?
Population
706 patients with chronic heart failure with reduced ejection fraction (HFrEF) and LVEF ≤45%
Comparison
Reversible abnormal tricuspid annular plane… vs Persistently normal TAPSE, worsening TAPSE, or…
Design
Cohort
Follow-up
median 40 months
Authors
Loading...
RV recovery on serial TAPSE may identify lower-risk chronic HFrEF; hypothesis-generating for modifiable RV targets.
Does a reversible abnormal TAPSE (right ventricular recovery) improve survival in patients with chronic HFrEF?
In patients with chronic HFrEF, recovery of right ventricular systolic function (reversible abnormal TAPSE) is associated with significantly improved survival, comparable to patients with persistently normal RV function.
Dini et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: